Search Results 751-760 of 16781 for Effets indésirables de la cortisone

1. A Study to Evaluate ALZT-OP1a in Subjects with Mild-to-Moderate Amyotrophic Lateral Sclerosis - Mayo Clinic

   ... effects of ALZT-OP1a (cromolyn) on functional changes in subjects with mild-moderate stage ALS by using the ALS Functional Rating Scale-Revised (ALSFRS-R) ...

2. A Study to Evaluate the Safety and Effectiveness of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia - Mayo Clinic

   ... effects, optimal dosages and risks/benefits. In ... Be on a stable, supraphysiologic glucocorticoid dose regimen (defined as > 13 mg/m^2/day in hydrocortisone ...

3. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   This study will also evaluate other anti-tumor effects, tumor markers and ... Subject using a physiologic replacement dose of hydrocortisone or its equivalent ( ...

4. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   ... effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard ...

5. A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer - Mayo Clinic

   This trial studies how well the drug tucatinib works when given with trastuzumab deruxtecan. It will also look at what side effects happen when these drugs are ...

6. Dermatology - Doctors - Mayo Clinic

   Learn about the expertise offered to people with conditions of the skin, mucous membranes and hair.

7. Carbidopa and levodopa (oral route) - Mayo Clinic

   No information is available on the relationship of age to the effects of Sinemet® or Parcopa® in geriatric patients. Breastfeeding. There are no adequate ...

8. A Study to Evaluate the Therapeutic Effectiveness of Rifaximin in Diabetic Gastroparesis Patients Using Bloating as the Primary Endpoint - Mayo Clinic

   ... effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard ...

9. General Internal Medicine - Clinical trials

   Positive results of this study would lead to the development of a larger clinical trial examining the effects of this intervention on age-related dysfunction.

10. Neurology - Clinical trials

    A Study to Evaluate Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this ...